Preclinical Studies in vivo demonstrated the involvement of FGF21 in the pathophysiologic mechanism of heart failure via protection against cardiac hypertrophy, oxidative stress, and inflammation in cardiomyocytes. Here, FGF21 is linked to cardiac hypertrophy.